STRATEC Biomedical AG (SBSG)

Xetra
Currency in EUR
33.900
-0.950(-2.73%)
Closed
SBSG Scorecard
Full Analysis
Trading at a high earnings multiple
Fair Value
Day's Range
33.50034.500
52 wk Range
26.05048.600
Key Statistics
Edit
Bid/Ask
33.90 / 33.90
Prev. Close
34.85
Open
34.5
Day's Range
33.5-34.5
52 wk Range
26.05-48.6
Volume
4.92K
Average Volume (3m)
9.3K
1-Year Change
-18.76%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SBSG Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
41.000
Upside
+20.94%
Members' Sentiments
Bearish
Bullish
ProTips
Has maintained dividend payments for 21 consecutive years
Show more

STRATEC Biomedical Company Profile

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Employees
1462
Market
Germany

Compare SBSG to Peers and Sector

Metrics to compare
SBSG
Peers
Sector
Relationship
P/E Ratio
41.0x21.4x−0.6x
PEG Ratio
−2.470.120.00
Price/Book
1.8x1.9x2.6x
Price / LTM Sales
1.6x1.8x3.1x
Upside (Analyst Target)
14.8%8.7%48.7%
Fair Value Upside
Unlock12.1%7.7%Unlock

Analyst Ratings

3 Buy
3 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 41.000
(+20.94% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.824
Dividend Yield
1.58%
Industry Median 0.68%
Annualised payout
0.5500
Paid annually
5-Years Growth
-7.68%
Growth Streak

Earnings

Latest Release
Oct 25, 2024
EPS / Forecast
0.05 / 0.38
Revenue / Forecast
57.20M / 57.20M
EPS Revisions
Last 90 days

FAQ

What Is the STRATEC Biomedical (SBSG) Stock Price Today?

The STRATEC Biomedical stock price today is 33.90.

What Stock Exchange Does STRATEC Biomedical Trade On?

STRATEC Biomedical is listed and trades on the Xetra stock exchange.

What Is the Stock Symbol for STRATEC Biomedical?

The stock symbol for STRATEC Biomedical is "SBSG."

Does STRATEC Biomedical Pay Dividends? What’s The Current Dividend Yield?

The STRATEC Biomedical dividend yield is 1.58%.

What Is the STRATEC Biomedical Market Cap?

As of today, STRATEC Biomedical market cap is 409.66M.

What is STRATEC Biomedical Earnings Per Share?

The STRATEC Biomedical EPS is 0.824.

What Is the Next STRATEC Biomedical Earnings Date?

STRATEC Biomedical will release its next earnings report on 26 Mar 2025.

From a Technical Analysis Perspective, Is SBSG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.